Literature DB >> 21479449

Methylation status of the long control region of HPV 16 in clinical cervical specimens.

Die Hong1, Feng Ye, Weiguo Lu, Ying Hu, Xiaoyun Wan, Yaxia Chen, Xing Xie.   

Abstract

DNA methylation is one of the regulatory pathways that modulate human papillomavirus (HPV) gene expression. To obtain detailed methylation information on crucial areas of the long control region (LCR) of HPV 16 and to clarify the significance of methylation in clinical cervical lesions, 80 clinical samples were examined to determine the methylation status of the HPV 16 promoter and enhancer core using bisulfite modification and pyrosequencing. Seventy samples [26 of cervical carcinoma (CC), 13 of cervical intraepithelia neoplasia (CIN) III, 17 of CIN I-II and 14 of asymptomatic HPV 16 infection] were successfully examined. Analysis of the general methylation status of HPV 16 LCR in the 70 clinical specimens revealed 43 (61.4%) with methylation in the promoter and/or enhancer core of HPV 16. The proportion of methylated samples was highest in CC specimens (84.6%), followed by asymptomatic infection (71.4%) and CIN III (46.2%), while the proportion of methylated samples was lowest in CIN I-II specimens (29.4%). The methylation status of eight CpGs in HPV 16 LCR was determined in detail. In general, the methylation of CpGs was more common in the promoter than in the enhancer core region. The methylation frequencies of the eight CpGs ranged from 14.6±7.2 to 33.7±23.0% in individual methylated CpG cases. The methylation pattern of all eight CpGs methylated in the promoter and enhancer core was more common in CC, and the pattern of scattered methylated CpGs was relatively more prevalent in asymptomatic infections. Our study demonstrates that DNA methylation is a common phenomenon in HPV 16 LCR clinical specimens, and may function as a host defense mechanism. While hypomethylation is probably associated with the initiation of neoplasia, hypermethylation in cervical cancer may be a reflection of the host defense mechanism. In the regulation of transcription, methylation is of more importance in the HPV 16 promoter than in the enhancer core.

Entities:  

Year:  2008        PMID: 21479449

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  15 in total

1.  Epigenetics of human papillomaviruses.

Authors:  Eric Johannsen; Paul F Lambert
Journal:  Virology       Date:  2013-08-13       Impact factor: 3.616

2.  Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN.

Authors:  Chandrika J Piyathilake; Maurizio Macaluso; Michelle M Chambers; Suguna Badiga; Nuzhat R Siddiqui; Walter C Bell; Jeffrey C Edberg; Edward E Partridge; Ronald D Alvarez; Gary L Johanning
Journal:  Cancer Prev Res (Phila)       Date:  2014-08-21

3.  Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China.

Authors:  Wei Wang; Zhengrong Sun; Jianhua Liu; Guili Wang; Zhitao Lu; Weiqiang Zhou; Te Qi; Qiang Ruan
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

Review 4.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

5.  HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer.

Authors:  Lisa Mirabello; Marina Frimer; Ariana Harari; Thomas McAndrew; Benjamin Smith; Zigui Chen; Nicolas Wentzensen; Sholom Wacholder; Philip E Castle; Tina Raine-Bennett; Mark Schiffman; Robert D Burk
Journal:  Int J Cancer       Date:  2014-09-03       Impact factor: 7.396

6.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

7.  Human Papillomavirus Type 16 L2 DNA Methylation in Exfoliated Cervical Cells From College-Age Women.

Authors:  Erin L Anderson; Carolyn E Banister; Susannah Kassler; Amy Messersmith; Lucia Pirisi; Kim E Creek; Michael D Wyatt
Journal:  J Low Genit Tract Dis       Date:  2016-10       Impact factor: 1.925

Review 8.  Molecular mechanisms of HPV mediated neoplastic progression.

Authors:  Rashmirani Senapati; Nihar Nalini Senapati; Bhagirathi Dwibedi
Journal:  Infect Agent Cancer       Date:  2016-11-25       Impact factor: 2.965

Review 9.  Aberrant DNA methylation in cervical carcinogenesis.

Authors:  Hui-Juan Yang
Journal:  Chin J Cancer       Date:  2012-08-28

10.  Characterization of HPV DNA methylation of contiguous CpG sites by bisulfite treatment and massively parallel sequencing-the FRAGMENT approach.

Authors:  Chang Sun; Thomas McAndrew; Benjamin C Smith; Zigui Chen; Marina Frimer; Robert D Burk
Journal:  Front Genet       Date:  2014-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.